These latter studies therefore cannot differentiate between initial abnormalities in the central gait network of RBD and LRRK2 cohorts (which can be entirely independent of dynamic processes happening in a prodromal PD phase) and “real” prodromal PD markers, thus highlighting the need for prospective longitudinal and population‐based studies. This evidence concerns the gene LRRK2 and Parkinson disease.